Inventor · disambiguated record
Clodagh O'Shea
Also filed as: O'SHEA CLODAGH · OSHEA Clodagh
14 granted patents·16 pending applications·82 citations·filing 2013–2025
91Inventor score
Files withSALK INST FOR BIOLOGICAL STUDI30
Top patents by PatentIndex Score
30 records- 0196US12281324B2Exogenous gene expression in recombinant adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Granted Apr 22, 2025·2 cites·35 claims
- 0295US11401529B2Exogenous gene expression in recombinant adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Granted Aug 2, 2022·3 cites·67 claims
- 0395US10738325B2Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Aug 11, 2020·10 cites·20 claims
- 0492US9217160B2Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2013·Granted Dec 22, 2015·13 cites·20 claims
- 0591US9913866B2Selective cell targeting using adenovirus and chemical dimersSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Mar 13, 2018·25 cites·10 claims
- 0691US9885090B2Adenoviral tumor diagnosticsSALK INST FOR BIOLOGICAL STUDI·Filed 2014·Granted Feb 6, 2018·9 cites·18 claims
- 0788US11130968B2High throughput assay for measuring adenovirus replication kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Sep 28, 2021·3 cites·21 claims
- 0887US10577589B2Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Mar 3, 2020·3 cites·15 claims
- 0986US9187733B2Anti-cancer adenovirusesSALK INST FOR BIOLOGICAL STUDI·Filed 2013·Granted Nov 17, 2015·10 cites·9 claims
- 1084US11077156B2Oncolytic adenovirus compositionsSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Aug 3, 2021·3 cites·26 claims
- 1183US2025146013A1High throughput assay for measuring adenovirus replication kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 1281US2025134941A1Hsv-1 oncolytic virus therapies that specifically kill alt dependent cancersSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 1380US10821141B2HSV-1 oncolytic virus therapies that specifically kill ALT dependent cancersSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Nov 3, 2020·1 cites·15 claims
- 1479US2024342231A1Selective cell targeting using adenovirus and chemical dimersSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 1578US2025382638A1Exogenous gene expression in recombinant adenovirus for minimal impact on viral kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2025·Application pending·0 cites
- 1678US2024207445A1Tumor-targeting synthetic adenoviruses and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 1775US2022411763A1Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2022·Application pending·0 cites
- 1872US2023364263A1Synthetic adenoviruses targeting bone tissue and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 1970US11813337B2Tumor-targeting synthetic adenoviruses and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Nov 14, 2023·0 cites·24 claims
- 2070US2022090123A1High throughput assay for measuring adenovirus replication kineticsSALK INST FOR BIOLOGICAL STUDI·Filed 2021·Application pending·0 cites
- 2168US2020149014A1Adenoviral assembly methodSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Application pending·0 cites
- 2266US2023218690A1Oncolytic adenovirus with replication selectivity based on status of p53 transcriptional activitySALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 2366US2023220355A1Recombinant adenovirus genome having a synthetic transcriptional unit and two step transcriptional regulation and amplificationSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Application pending·0 cites
- 2464US2021220417A1Hsv-1 oncolytic virus therapies that specifically kill alt dependent cancersSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Application pending·0 cites
- 2560US2019314525A1Synthetic adenoviruses targeting bone tissue and uses thereofSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Application pending·0 cites
- 2658US2018100204A1Adenoviral tumor diagnosticsSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Application pending·0 cites
- 2754US12365878B2Oncolytic adenovirus with enhanced replication properties comprising modifications in E1A, E3, and E4SALK INST FOR BIOLOGICAL STUDI·Filed 2020·Granted Jul 22, 2025·0 cites·35 claims
- 2854US11730781B2Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regenerationSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Aug 22, 2023·0 cites·11 claims
- 2954US2020308239A1Genetically encoded fluorescent-iron ferritin nanoparticle probes for detecting an intracellular target by fluorescent and electron microscopySALK INST FOR BIOLOGICAL STUDI·Filed 2020·Application pending·0 cites
- 3052US2018147245A1Selective cell targeting using adenovirus and chemical dimersSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clodagh O'Shea files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →